Naoki Ishiuchi

446 total citations
26 papers, 286 citations indexed

About

Naoki Ishiuchi is a scholar working on Genetics, Surgery and Nephrology. According to data from OpenAlex, Naoki Ishiuchi has authored 26 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Surgery and 11 papers in Nephrology. Recurrent topics in Naoki Ishiuchi's work include Mesenchymal stem cell research (12 papers), Dialysis and Renal Disease Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Naoki Ishiuchi is often cited by papers focused on Mesenchymal stem cell research (12 papers), Dialysis and Renal Disease Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Naoki Ishiuchi collaborates with scholars based in Japan, Netherlands and Malaysia. Naoki Ishiuchi's co-authors include Ayumu Nakashima, Takao Masaki, Shigehiro Doi, Satoshi Maeda, Yukio Kato, Yumi Yamada, Toshiki Doi, Ken Yoshida, Kensuke Sasaki and Masataka Nagao and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of the American Society of Nephrology.

In The Last Decade

Naoki Ishiuchi

19 papers receiving 285 citations

Peers

Naoki Ishiuchi
Chengshu Tu China
Sonja Wagner Austria
Arigue A. Dessouky Egypt
Zongyan Xie China
Yosuke Saka Japan
Mi Ra Kim South Korea
Abdelrhman Abumoawad United States
Krzysztof Bojakowski Poland
Dalong Zhu China
Sara Gallo Italy
Chengshu Tu China
Naoki Ishiuchi
Citations per year, relative to Naoki Ishiuchi Naoki Ishiuchi (= 1×) peers Chengshu Tu

Countries citing papers authored by Naoki Ishiuchi

Since Specialization
Citations

This map shows the geographic impact of Naoki Ishiuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Ishiuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Ishiuchi more than expected).

Fields of papers citing papers by Naoki Ishiuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Ishiuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Ishiuchi. The network helps show where Naoki Ishiuchi may publish in the future.

Co-authorship network of co-authors of Naoki Ishiuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Ishiuchi. A scholar is included among the top collaborators of Naoki Ishiuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Ishiuchi. Naoki Ishiuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Yoshiki, Ayumu Nakashima, Naoki Ishiuchi, et al.. (2025). Overexpression of Thrombomodulin in Adipose-Derived Mesenchymal Stem Cells Reduces Thrombogenic Risk and Enhances Therapeutic Efficacy. Journal of the American Society of Nephrology. 37(1). 85–100.
2.
3.
4.
5.
6.
7.
Morimoto, Keisuke, Ayumu Nakashima, Naoki Ishiuchi, et al.. (2024). Mesenchymal Stem Cells Overexpressing Tumor Necrosis Factor α-Induced Protein 6 Have an Enhanced Inhibitory Effect on Kidney Fibrosis. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
8.
Sasaki, Kensuke, Ryo Tamura, Akira Takahashi, et al.. (2024). Selective activation of PPARα by pemafibrate mitigates peritoneal inflammation and fibrosis through suppression of NLRP3 inflammasome and modulation of inflammation. Scientific Reports. 14(1). 3 indexed citations
9.
Nakashima, Ayumu, Naoki Ishiuchi, Yoshiki Tanaka, et al.. (2024). Impact of immunosuppressive drugs on efficacy of mesenchymal stem cell therapy for suppressing renal fibrosis. Stem Cells Translational Medicine. 13(11). 1067–1085.
10.
Nakashima, Ayumu, Naoki Ishiuchi, Keisuke Morimoto, et al.. (2023). Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis. International Journal of Molecular Sciences. 24(23). 16920–16920. 7 indexed citations
11.
12.
Ishiuchi, Naoki, Ayumu Nakashima, Satoshi Maeda, et al.. (2023). Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues. Stem Cell Research & Therapy. 14(1). 121–121. 8 indexed citations
13.
Nakashima, Ayumu, Naoki Ishiuchi, Kensuke Sasaki, et al.. (2023). Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects. Stem Cell Research & Therapy. 14(1). 337–337. 4 indexed citations
14.
Sasaki, Kensuke, Ayumu Nakashima, Akira Takahashi, et al.. (2023). Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching. Clinical and Experimental Nephrology. 27(5). 419–426. 3 indexed citations
15.
Namera, Akira, Takeshi Saito, Kanji Yoshimoto, et al.. (2022). A method for determining valproic acid in human whole blood and urine via gas chromatography-mass spectrometry and small-scale inter-laboratory trial. Legal Medicine. 59. 102133–102133. 4 indexed citations
16.
Murata, Kazuhiro, Naoki Nakao, Naoki Ishiuchi, et al.. (2022). Four cases of cytokine storm after COVID-19 vaccination: Case report. Frontiers in Immunology. 13. 967226–967226. 23 indexed citations
17.
Nakashima, Ayumu, Ryo Tamura, Naoki Ishiuchi, et al.. (2021). Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis. Stem Cell Research & Therapy. 12(1). 203–203. 21 indexed citations
18.
Ishiuchi, Naoki, Ayumu Nakashima, Shigehiro Doi, et al.. (2021). Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis. Stem Cell Research & Therapy. 12(1). 472–472. 20 indexed citations
19.
Nakashima, Ayumu, Shigehiro Doi, Ken Yoshida, et al.. (2021). Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis. Scientific Reports. 11(1). 850–850. 44 indexed citations
20.
Ishiuchi, Naoki, Ayumu Nakashima, Shigehiro Doi, et al.. (2020). Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Research & Therapy. 11(1). 130–130. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengshu Tu Breakdown of academic impact, for papers by Sonja Wagner Breakdown of academic impact, for papers by Arigue A. Dessouky Breakdown of academic impact, for papers by Zongyan Xie Breakdown of academic impact, for papers by Yosuke Saka Breakdown of academic impact, for papers by Mi Ra Kim Breakdown of academic impact, for papers by Abdelrhman Abumoawad Breakdown of academic impact, for papers by Krzysztof Bojakowski Breakdown of academic impact, for papers by Dalong Zhu Breakdown of academic impact, for papers by Sara Gallo
Rankless by CCL
2026